Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines

Several effective SARS-CoV-2 vaccines have been developed using different technologies. Although these vaccines target the isolates collected early in the pandemic, many have protected against serious illness from newer variants. Nevertheless, efficacy has diminished against successive variants and...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaria, Puthupparampil V., Rowe, Chris G., Chen, Beth B., Dickey, Thayne H., Renn, Jonathan P., Lambert, Lynn E., Barnafo, Emma K., Rausch, Kelly M., Tolia, Niraj H., Duffy, Patrick E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270177/
https://www.ncbi.nlm.nih.gov/pubmed/35846379
http://dx.doi.org/10.1016/j.isci.2022.104739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270177/
https://www.ncbi.nlm.nih.gov/pubmed/35846379
http://dx.doi.org/10.1016/j.isci.2022.104739

Ejemplares similares